HC Wainwright Upgrades Inovio to Buy, Sets $5 Price Target
HC Wainwright raised its rating on Inovio Pharmaceuticals from Neutral to Buy and set a $5 price target. The target implies 730.0% upside from the Oct. 30 close of $0.60.
Related stories
Engineers India Shares Jump 15% to Two-Week High After Q2 Results
Engineers India shares closed Monday up 15% at Rs.290, a two-week high, after upbeat September-quarter results. The stock has gained 44% in 2026.
M impact | EQUITY | Nov 02, 2026, 03:48 PM UTC
World Stocks Rebound as Oil Falls and Strong Data Is Published
Global equities rebounded as oil prices declined and strong economic data was published.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Carnelian, HDFC AMC and L&T Acquire 2.9% Stake in EAAA India Alternatives
The investors collectively acquired the stake through open-market transactions on EAAA India Alternatives’ first day of trading, November 2.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global stocks rise as oil falls and data prove positive
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global Stocks Rise as Oil Pullback and Solid Data Lift Sentiment
Global stocks were headed higher after oil prices fell sharply, reversing some of the gloom from Friday’s US tech rout. The Nasdaq was up 1.2% and the S&P 500 rose 1% at the open.
M impact | EQUITY | Nov 02, 2026, 03:46 PM UTC
Cencosud Closes Four Easy Stores in Chile
Cencosud closed four stores in its Easy chain: two in regional areas and two in Santiago.
L impact | EQUITY | Nov 02, 2026, 03:42 PM UTC